As the push for the legalisation of psychedelics continues, questions around safety and harm reduction should continue to be raised. If psychedelics were legalised for non-medical use in certain US states and countries, they would need to be regulated. But there are differing opinions on what this model of regulation should look like. The commercial…
View Post
Hallucinogen persisting perception disorder (HPPD) is a rare condition that can develop after psychedelic use. HPPD involves persisting visual changes that cause emotional distress and/or impairment to functioning. It is not clear precisely how prevalent the condition is, although its prevalence is considered low. In one study, 4.2% of participants said they experienced continued visual…
View Post
5-MeO-DMT is widely considered to be the most powerful psychedelic. This is not due to the dosages needed to reach intense altered states – technically, the most potent psychedelic in that respect is LSD, with Salvia divinorum being the most potent naturally occurring psychedelic, given that active doses of Salvinorin A are as low as…
View Post
Not everyone in favour of changes to psychedelic drug policy has the same policy outcomes in mind. While the basis for this desire to end the criminalisation of psychedelic use may be the same – such as the defence of cognitive liberty – there can be disagreements about the best way to grant this right,…
View Post
It’s often assumed, because of the therapeutic potential of psychedelic drugs, that tripping can help people shed nihilistic and depressive worldviews. In fact, this does happen for many, with feelings of existential joy and a yes-saying to the world suffusing the psychedelic state – and these feelings of optimism and life affirmation can carry over…
View Post